Evidence map›Paper›PMID 33013353›Full record

ArticleFrontiers in pharmacology2020

Inhibition of JNK-Mediated Autophagy Promotes Proscillaridin A- Induced Apoptosis

Muhammad Zubair Saleem, Mohammed Alshwmi, He Zhang, Syed Riaz Ud Din, Muhammad Azhar Nisar, Muhammad Khan, Shahid Alam, Gulzar Alam, Lingling Jin, Tonghui Ma

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Oxidative Stress in Cancer Cell Metabolism.Antioxidants (Basel, Switzerland) · 2021
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Muhammad Zubair SaleemCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Mohammed AlshwmiDepartment of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
He ZhangCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Syed Riaz Ud DinCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Muhammad Azhar NisarCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Muhammad KhanDepartment of Zoology, University of the Punjab, Lahore, Pakistan.
Shahid AlamDepartment of Anatomy, Dalian Medical University, Dalian, China.
Gulzar AlamAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Lingling JinCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Tonghui MaCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Dalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CNUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most heterogenous cancer type among women across the world. Despite concerted efforts, breast cancer management is still unsatisfactory. Interplay between apoptosis and autophagy is an imperative factor in categorizing therapeutics for cancer treatment. Proscillaridin A (PSD-A), a well-known cardiac glycoside used for cardiac arrest and arrythmias, has been unveiled in many cancer types but the underlying mechanism for apoptosis and autophagy in breast cancer is not fully understood. In our study, PSD-A restricted cell growth, inhibited STAT3 activation and induced apoptosis and autophagy in breast cancer cells

Indexed as

apoptosisautophagybreast cancerc-Jun N-terminal kinaseproscillaridin Asignal transducer and activator of transcription 3 (STAT3)

Identifiers

PMID33013353
PMCPMC7500466
OpenAlexW3083078199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.